Monitor for potential business combination targets in biotechnology, healthcare, or technology sectors. Watch for conflicts of interest between sponsor/management and public shareholders. Track redemption rates as business combination approaches, as high redemption could jeopardize deal completion.
Executive Summary
Blue Water Acquisition Corp. IV (BWIV) is a blank check company formed to complete a business combination with a target in biotechnology, healthcare, or technology. The company raised $125 million through an IPO of 12.5 million units at $10 each, with each unit consisting of one Class A ordinary share and half a warrant. Founder shares were issued to the sponsor at a nominal price, creating significant dilution for public shareholders. The company has 21 months to complete a business combination, with funds held in trust subject to redemption rights.
Key Financial Metrics
Key Facts
- BWIV is a blank check company formed to complete a business combination in biotechnology, healthcare, or technology sectors
- Raised $125 million through IPO of 12.5 million units at $10 each
- Each unit consists of one Class A ordinary share and half a redeemable warrant
- Founder shares issued to sponsor at $0.005 per share, creating significant dilution for public shareholders
- Has 21 months to complete a business combination
- Funds held in trust subject to redemption rights if business combination not completed
- Sponsor and officers may have conflicts of interest in target selection
Financial Impact
Raised $125 million in IPO proceeds with $125 million placed in trust account
Risk Factors
- Significant dilution for public shareholders due to founder shares issued at nominal price
- Conflicts of interest between sponsor/management and public shareholders
- Risk of not completing business combination within 21-month window
- Potential for high redemption rates jeopardizing business combination
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001493152-26-009583 |
| Exhibit: ex3-2.htm | 0001493152-26-009583 |
| Exhibit: ex1-1.htm | 0001493152-26-009583 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 6, 2026 24w ago | 8-K | $10.08 $10.04 | ▼ −0.40% | ▼ −3.18% | $9.98 (−0.99%) |
Apr 28, 2026 26w ago | 8-K / 425 | $10.09 $10.10 | ▲ +0.10% | ▼ −5.95% | $9.98 (−1.09%) |
Mar 20, 2026 31w ago | 424B4 | — | awaiting T+20 | — | — |
Mar 20, 2026 31w ago | EFFECT | — | awaiting T+20 | — | — |
Mar 11, 2026 32w ago | S-1/A | — | awaiting T+20 | — | — |
Feb 24, 2026 35w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers